COVID-19 and Public Health | Johns Hopkins | Bloomberg School of Public Health

Scientists’ Uncertain Future

May 20, 2025

U.S. researchers face sudden funding cuts that threaten studies, careers, and scientific progress.

COVID-19

Health Equity

Infectious Diseases

Public Health Magazine

Bloomberg School Researchers Support First Blood Center to Receive Full FDA Approval to Provide Convalescent Plasma for Patients Who Are Immunocompromised

January 13, 2025

Arturo Casadevall, MD, PhD, and David Sullivan, MD, recommend exploring using convalescent plasma at scale in public health preparedness planning for future disease outbreaks and pandemics.

COVID-19

Infectious Diseases

Medicine

Department of Molecular Microbiology and Immunology

A collage of images representing public health in 2024, including a woman pushing an older woman in a wheelchair, a pair of hands with mpox, a woman wiping her brow in the heat, a bottle of pills spilling, a woman protesting for abortion rights, a dairy cow, a child filling a water glass, a pile of condoms, a police officer putting up caution tape, a child with measles, a covid particle, and a road sign that says "uncertainty ahead."

Public Health in 2024: Historic Firsts, Unwelcome Comebacks, and Rays of Hope

December 18, 2024

As we head into 2025—a year certain to bring great change—we reflect on 2024’s public health headlines.

Reproductive and Sexual Health

Substance Use Disorder

Vaccines

Bloomberg School

Wider Use of Convalescent Plasma Might Have Saved Thousands More Lives During Pandemic

October 03, 2024

Authors say findings support considering convalescent plasma deployment for future infectious diseases emergencies

COVID-19

Infectious Diseases

Medicine

Bloomberg School

A woman enters a pharmacy after a Russian drone attack on January 31, 2024 in Kharkiv, Ukraine; the letters on the sign (anteka, which means pharmacy in Ukraine) are damaged and falling off the building front.

Pandemic Agreement May Happen Eventually ... But Will the World Be Ready?

September 20, 2024

Countries do not need to wait until WHO member states reach consensus to begin the essential, though perhaps less exciting, behind-the-scenes system-strengthening work to prepare for the implementation of the pandemic accord.

COVID-19

Infectious Diseases

International Health

Global Health NOW

covid vaccine vials, syringes, and bandaids on a metal tray

What to Know About the Updated COVID Vaccine for Fall, Winter 2024–25

August 25, 2024

The updated COVID vaccine provides safe, effective protection against current variants for everyone 6 months and older.

COVID-19

Infectious Diseases

Vaccines

Bloomberg School

COVID-19 Faculty Experts

Looking for prominent public health experts in the field of COVID-19? They’re here at the Bloomberg School of Public Health.

Sabra Klein, PhD '98, studies sex differences and the effects of pregnancy on immune responses to viruses, including influenza viruses and SARS-Cov-2, and vaccines.

COVID-19

COVID-19 Headlines

Scientists’ Uncertain Future

Bloomberg School Researchers Support First Blood Center to Receive Full FDA Approval to Provide Convalescent Plasma for Patients Who Are Immunocompromised

Public Health in 2024: Historic Firsts, Unwelcome Comebacks, and Rays of Hope

Wider Use of Convalescent Plasma Might Have Saved Thousands More Lives During Pandemic

Pandemic Agreement May Happen Eventually ... But Will the World Be Ready?

What to Know About the Updated COVID Vaccine for Fall, Winter 2024–25

COVID-19 Faculty Experts

Caitlin M. Rivers

William John Moss

Amesh Adalja

Sabra L. Klein

Departments

Programs